In the first session from the TAVI Round Table Discussion, the assembled panel of internationally-recognised opinion leaders discuss interpreting TAVI research data.
Designed to support the continuous education of practicing physicians, this first session shares leading opinion and addresses the following questions and key educational objectives:
- Is TAVI effective?
- Is TAVI cost-effective?
- How useful are risk scoring and frailty assessment?
- How to manage asymptomatic high risk patients.
- Is it appropriate to treat intermediate risk patients with currently available technology?
The panel for this session comprises:
- Simon Kennon (Chair), London Chest Hospital, UK
- Enrico Ferrari, Cardiovascular Surgery Department, University Hospital of Lausanne, Switzerland
- Carlos Ruiz, Lenox Hill Heart and Vascular Institute of New York, US
- Lars Søndergaard, Rigshospitalet Copenhagen University Hospital, Denmark
- Corrado Tamburino, University of Catania, Catania, Italy
Radcliffe Cardiology and Interventional Cardiology Review extend their thanks to all panel members.